Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052481 · ClinicalTrials.gov registry record
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
A clinical trial of Prostate Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 500
- Enrollment target
- 13
- Study locations
NCT00052481 is a study of Prostate Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 500 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The trial reports 13 study locations across 11 states.
The verdict
NCT00052481, a study of Prostate Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 13
- Study locations
Study Summary
RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate-term and long-term effects of surgery and brachytherapy. PURPOSE: Randomized clinical trial to study quality of life in patients undergoing radical prostatectomy or brachytherapy for stage II prostate cancer.
Conditions Studied
Interventions
- PROCEDURE quality-of-life assessment
Study Locations (13)
New York
- Memorial Sloan-Kettering Cancer Center - New York
- James P. Wilmot Cancer Center at University of Rochester Medical Center - Rochester
Washington
- University Cancer Center at University of Washington Medical Center - Seattle
- Madigan Army Medical Center - Tacoma
California
- UCSF Comprehensive Cancer Center - San Francisco
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Iowa
- Holden Comprehensive Cancer Center at University of Iowa - Iowa City
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Missouri
- Washington University School of Medicine - St Louis
North Carolina
- Presbyterian Hospital - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2002-09 |
| Est. Completion | 2004-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052481
The ClinicalTrials.gov registry entry for NCT00052481 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which quality-of-life assessment is the first listed.
NCT00052481 reports 13 study locations spanning 11 distinct geographic areas - top geographies include New York, Washington, California.
Frequently Asked Questions
What is clinical trial NCT00052481 about?
NCT00052481 is a clinical study titled "Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer". RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate-term and long-term effects of surgery and brachytherapy. PURPOSE: Randomized clinical trial to study quality of life in patients undergoing radical prostatectomy or brachythera...
What is the current status of trial NCT00052481?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2002-09. Estimated completion is 2004-04.
What conditions does trial NCT00052481 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00052481?
The interventions under investigation include: quality-of-life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT00052481?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00052481 being conducted?
This trial has 13 study locations across California, District of Columbia, Iowa, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.